Tracers Or Tags Patents (Class 436/56)
-
Publication number: 20120034699Abstract: A nucleic acid tag comprising a nucleotide-support platform attached to a nucleic acid molecule, an odorant, and an encapsulant. Unique nucleic acid-containing tags containing an odorant are seeded at one or more geographic locations. Using odorant-detection systems, the person or object of interest is examined for the presence of one or more of the odorant, thereby revealing the presence of the seeded nucleic acids and eliminating the expense and time associated with unnecessary screening. The geographic location associated with each detected nucleic acid is used to backtrack the item's path or extrapolate a probable point of origin.Type: ApplicationFiled: August 3, 2010Publication date: February 9, 2012Applicant: SRC, INC.Inventor: Mary F. Bronchetti
-
Patent number: 8097463Abstract: Tagging of Histidine in polypeptides with arylboronic acid tagging reagents for identifying proteins in a sample by isolating and identifying Histidine-comprising peptides from one protein sample or a pool of protein samples. Databases of Histidine-including peptides from in silico cleaved proteins are uses in the identification of proteins.Type: GrantFiled: October 26, 2007Date of Patent: January 17, 2012Assignee: Koninklijke Philips Electronics N.V.Inventors: Ralf Hoffmann, Helga Hummel, Volker Weiler
-
Patent number: 8092758Abstract: A sample acquiring device for volumetric enumeration of white blood cells in a blood sample comprises a measurement cavity for receiving a blood sample. The measurement cavity has a predetermined fixed thickness. The sample acquiring device further comprises a reagent, which is arranged in a dried form on a surface defining the measurement cavity. The reagent comprises a hemolysing agent for lysing red blood cells in the blood sample, and a staining agent for selectively staining white blood cells in the blood sample. A system comprises the sample acquiring device and a measurement apparatus. The measurement apparatus comprises a sample acquiring device holder, a light source, and an imaging system for acquiring a digital image of a magnification of the sample. The measurement apparatus further comprises an image analyser arranged to analyse the acquired digital image for determining the number of white blood cells in the blood sample.Type: GrantFiled: March 10, 2006Date of Patent: January 10, 2012Assignee: Hemocue ABInventors: Stellan Lindberg, Johnny Svensson
-
Patent number: 8080383Abstract: A subject of the invention is a method for discriminating between and counting at least two populations of biological elements carrying specific characteristics, optionally present in a sample. The invention allows the clear and unambiguous detection of at least three populations of biological elements by the use of only two detection means, which means that at least two populations of biological elements are detected by one and the same detection means. The invention can be carried out if three different probes are used, each recognizing and becoming fixed to one of the populations of biological elements to be detected, each of the probes being itself rendered detectable by a different marker, two of said markers having two emission spectra having at least one common part (overlapping emission spectra) and the third having an emission spectrum having essentially no part in common with the other two (non-overlapping spectrum).Type: GrantFiled: December 5, 2006Date of Patent: December 20, 2011Assignee: Horiba Abx Sas, Parc EuromedicineInventors: Francis Lacombe, Francis Belloc, Sylvie Veriac, Didier Lefevre
-
Publication number: 20110306141Abstract: A nucleic acid tag comprising a nucleotide-support platform attached to a nucleic acid molecule, a fire retardant, and an encapsulant. Unique nucleic acid-containing tags containing a fire- or heat-protective element are seeded at one or more geographic locations. Using sequence analysis techniques, the person or object of interest is examined for the presence of one or more of the seeded nucleic acids. The geographic location associated with each detected nucleic acid is used to backtrack the item's path or extrapolate a probable point of origin.Type: ApplicationFiled: June 15, 2010Publication date: December 15, 2011Applicant: SRC, INC.Inventors: Mary F. Bronchetti, Laura T. Bortolin
-
Patent number: 8071386Abstract: A method and means for identifying the authenticity and the genuine nature of a solid or liquid bulk material, by incorporating a marking composition containing at least one trace ion into the said bulk material, whereby the total concentration of the incorporated trace ions in the market bulk material is chosen to be lower than the corresponding concentration of the same ions in standard sea water. The authenticity and the genuine nature or the adulteration level of the marked bulk material can be tested in-the-field using electrochemical sensors, and confirmed in the laboratory using a method such as atomic absorption spectroscopy, ion chromatography or mass spectrometry.Type: GrantFiled: May 19, 2004Date of Patent: December 6, 2011Assignee: SICPA Holding SAInventors: Thomas Tiller, Sylvain Jaquier, Xavier Marguerettaz
-
Patent number: 8053744Abstract: A method for using information encrypted with a nucleic acid molecule to backtrack an item's path or identify a point of origin. Unique nucleic acid-containing tags are seeded at one or more geographic locations. Using sequence analysis techniques, the person or object of interest is examined for the presence of one or more of the seeded nucleic acids. The geographic location associated with each detected nucleic acid is used to backtrack the item's path or extrapolate a probable point of origin.Type: GrantFiled: April 13, 2009Date of Patent: November 8, 2011Assignee: SRC, Inc.Inventor: Laura Bortolin
-
Patent number: 8053240Abstract: The invention relates to chemical formulations that can be used to render such chemicals easier to identify upon application to a surface. In one embodiment, the present invention relates to formulations designed to render herbicides, fungicides, pesticides, insecticides and/or phytotoxins easier to identify upon application to one or more types of vegetation. In another embodiment, the present invention relates to formulations designed to render water-soluble herbicides, fungicides, pesticides, insecticides and/or phytotoxins easier to identify upon application to one or more types of vegetation.Type: GrantFiled: December 1, 2009Date of Patent: November 8, 2011Inventor: Joseph James Crimaldi
-
Patent number: 8053194Abstract: Disclosed is a labeling substance capable of reversibly immobilizing (reversible detachment) to a solid surface and to reliably and accurately identify a target biological substance interacting with a probe substance bound to the labeling substance. A chimeric compound is provided, which includes a labeling substance L including (1) an organic compound S with a chemical structure capable of binding to a probe substance P, which can interact with a biological substance B and (2) a peptide bound to the organic compound S and specifically recognized by an antibody A, peptide and a probe substance P at least except a peptide or protein. In addition, a method for preparing the labeling substance L and a method for capturing, structurally analyzing and/or identifying the biological substance using the labeling substance L are provided.Type: GrantFiled: March 30, 2005Date of Patent: November 8, 2011Inventors: Kazuo Shinya, Tohru Natsume, Takayuki Doi
-
Patent number: 8039264Abstract: Methods, compositions, and kits for labeling tetracysteine-tagged proteins with biarsenical fluorophores with increased specificity, including compositions, methods and kits particularly adapted for labeling of tetracysteine-tagged proteins to be resolved within an electrophoresis gel.Type: GrantFiled: July 28, 2009Date of Patent: October 18, 2011Assignee: Life Technologies CorporationInventors: Roumen Bogoev, Joseph Amshey, George Hanson
-
Patent number: 8039220Abstract: Use of busulfan amide as stabilized standards in immunoassays for quantifying the amount of busulfan in samples of human biological fluids, methods for carrying out said immunoassay and kits for use in said immunoassay.Type: GrantFiled: September 17, 2008Date of Patent: October 18, 2011Assignee: Saladax Biomedical Inc.Inventors: Salvatore J. Salamone, Jodi Blake Courtney, Yunying Li
-
Patent number: 8030095Abstract: A gel microdrop composition is provided. In certain embodiments, the gel microdrop composition contains a polymer matrix, an effector particle that releases an effector molecule into the polymer matrix, a first reporter particle that emits a first optically detectable signal and a second reporter particle that emits a second optically detectable signal that is distinguishable from the first optically detectable signal, where the effector particle and said first and second reporter particles are encapsulated by the polymer matrix. Methods of screening that employ the gel microdrop composition and methods of making the gel microdrop composition are also disclosed.Type: GrantFiled: March 2, 2009Date of Patent: October 4, 2011Assignee: Crystal Bioscience Inc.Inventor: William Don Harriman
-
Patent number: 8012433Abstract: A device for dispersing a sample of dry powder onto a surface in a dispersion chamber. The device includes a dispersion chamber situated in an environment, and a pressure source that provides a pressure difference between the environment and an inside of the dispersion chamber. The surface is positioned in the dispersion chamber. The sample of dry powder is introduced into the dispersion chamber through a membrane that is interposed between the environment and the inside of the dispersion chamber and on which the sample is disposed. The membrane is rupturable so as to open into the dispersion chamber when a predetermined pressure difference across the membrane is exceeded. This permits entry of a fluid in the environment through the ruptured membrane, and movement of the dry powder sample in an evenly dispersed manner without producing an ordered movement of powder grains in the dispersion chamber.Type: GrantFiled: December 21, 2010Date of Patent: September 6, 2011Assignee: Occhio Parc Scientifique Du Sart TilmanInventors: Vincent Chapeau, Christian Godino
-
Patent number: 8008032Abstract: Method of enriching specific cells from cellular samples are disclosed, comprising contacting in solution a cellular sample with affinity-tagged ligands (ATLs) each comprising a first ligand linked to an affinity tag, wherein the ligand selectively binds a cellular marker of the rare cells and the affinity tag can be selectively captured by a capture moiety, wherein the affinity tags do not comprise a magnetic particle; and flowing the sample through a microfluidic device comprising the capture moiety to selectively retain ATL-bound cells. Methods for enriching circulating tumor cells, and devices for enriching specific cells from cellular samples are also disclosed.Type: GrantFiled: February 25, 2008Date of Patent: August 30, 2011Assignee: Cellective DX CorporationInventors: Allyn Forsyth, Helen Barnes
-
Patent number: 7985589Abstract: The invention provides a calibrating method for use in a method of determining the quantity of an analyte labeled with an accelerator mass spectrometry (AMS) isotope in a test sample. The samples can include, for example, urine, faeces, plasma or blood. The analyte can be, for example, a drug or metabolite of a drug.Type: GrantFiled: January 19, 2010Date of Patent: July 26, 2011Assignee: Xceleron, LimitedInventors: Ronald Colin Garner, Graham John Lappin
-
Patent number: 7977102Abstract: Compounds having stable isotopes 13C and/or 2H were synthesized from precursor compositions having solid phase supports or affinity tags.Type: GrantFiled: June 15, 2007Date of Patent: July 12, 2011Assignee: Los Alamos National Security, LLCInventors: Jurgen G. Schmidt, David B. Kimball, Marc A. Alvarez, Robert F. Williams, Rudolfo A. Martinez
-
Patent number: 7964407Abstract: Methods of marking products and of determining the origin or authenticity of marked products are provided that use a variety of natural materials as markers. The natural materials have unique genetically controlled micromorphological structures that can be identified using enhanced visualization techniques. For example, cellulosic plant materials, sporopollenin and diatoms can be used as the natural materials. The natural materials are added to products at sufficiently low levels so as not to have any significant effect on the products other than serving as markers. Dyes and reactants can be added to the natural materials to provide secondary markers. The secondary markers can be vacuum infused into hollow interior spaces of the materials, or placed in surface voids of the materials to remain secured in the marker structures until examined. Sub-cellular particles or heat sensitive molecules can also be used to provide a molecular thermometer for the markers.Type: GrantFiled: July 21, 2004Date of Patent: June 21, 2011Inventor: Lynn S. Bates
-
Patent number: 7960131Abstract: A method of assaying nucleotide receptor P2X7 pore activity in white blood cells contained within a mixed cell sample is provided comprising labeling white blood cells with a white blood cell-specific label; depolarizing the labeled white blood cells with an isotonic depolarizing solution; contacting the labeled white blood cells with dye and a P2X7 agonist in an amount sufficient to activate P2X7 pore activity; contacting the labeled white blood cells with a divalent cation in an amount sufficient to deactivate P2X7 pore activity; and analyzing dye uptake whereby P2X7 pore activity is quantified by the amount of dye taken up in labeled white blood cells treated with the P2X7 agonist relative to labeled white blood cells in the absence of said P2X7 agonist, said P2X7 pore activity being corrected for sample age and by subtraction of P2X7 pore activity contributed by nonviable white blood cells.Type: GrantFiled: June 3, 2008Date of Patent: June 14, 2011Assignee: Wisconsin Alumni Research FoundationInventors: Loren C. Denlinger, Kirk J. Hogan, Paul J. Bertics, Kathleen Schell
-
Patent number: 7943381Abstract: A system for automatically testing a fluid specimen, e.g., urine, to indicate the presence of specified chemical components in the specimen. The system preferably utilizes an assaying device comprised of a collection cup and a cap which carries at least one test strip. The device includes an integrated aliquot delivery mechanism actuatable to wet the test strip with an aliquot delivered from the fluid specimen. The assaying device is configured to operate in conjunction with an electronic reader device capable of actuating the aliquot delivery mechanism and reading the reaction of the test strip. A preferred reader device defines a keyed receptacle for accommodating a complementary shaped cup housing in a particular orientation. The reader device is comprised of a camera for capturing the image of a test strip, an actuator for actuating an aliquot delivery mechanism, and a microprocessor/controller for (1) controlling the camera and actuator and (2) processing the image.Type: GrantFiled: October 27, 2006Date of Patent: May 17, 2011Assignee: eScreen, Inc.Inventors: Murray Lappe, David A. Birkner, John Goodin, Keith Patten, Bill Whitford
-
Publication number: 20110111510Abstract: The present invention relates, generally to a method of determining and assessing cytochrome P450 2C19-related (CYP2C19) metabolic capacity in an individual mammalian subject via a breath assay, by determining the relative amount of 13CO2 exhaled by the subject upon intravenous or oral administration of a 13C-labeled CYP2C19 substrate compound. The present invention is useful as anon-invasive, in vivo assay for evaluating CYP2C19 enzyme activity in a subject using the metabolite 13CO2 in expired breath, to phenotype individual subjects and to determine the selection, optimal dosage and timing of drug administration.Type: ApplicationFiled: November 9, 2010Publication date: May 12, 2011Inventors: David A. Flockhart, Zeruesenay Desta, Anil S. Modak, Yasuhisa Kurogi
-
Patent number: 7939278Abstract: The present invention provides an approach for the simultaneous determination of the activation states of a plurality of proteins in single cells. This approach permits the rapid detection of heterogeneity in a complex cell population based on activation states, and the identification of cellular subsets that exhibit correlated changes in activation within the cell population. Moreover, this approach allows the correlation of cellular activities or properties. In addition, the use of potentiators of cellular activation allows for characterization of such pathways and cell populations.Type: GrantFiled: January 17, 2008Date of Patent: May 10, 2011Assignee: The Board of Trustees of Leland Stanford Junior UniversityInventors: Omar D. Perez, Garry P. Nolan, Jonathan M. Irish
-
Patent number: 7939338Abstract: A magnetic sensor array including magnetoresistive sensor elements having outputs combined by frequency division multiplexing (FDM) is provided. Each sensor element provides an input to a mixer which provides a distinct frequency shift. Preferably, time division multiplexing is also used to combine sensor element outputs. Each sensor element is typically in proximity to a corresponding sample. The sensor elements are preferably subarrays having row and column addressable sensor element pixels. This arrangement provides multiple sensor pixels for each sample under test. Multiplexing of sensor element outputs advantageously reduces readout time. A modulated external magnetic field is preferably applied during operation, to reduce the effect of 1/f noise on the sensor element signals. The effect of electromagnetic interference (EMI) induced by the magnetic field on sensor element signals is advantageously reduced by the mixing required for FDM.Type: GrantFiled: May 11, 2005Date of Patent: May 10, 2011Assignee: The Board of Trustees of the Leland Stanford Junior UniversityInventors: Shan X. Wang, Shu-Jen Han
-
Publication number: 20110104811Abstract: The present invention relates to a particle comprising a core which comprises an oxide selected from rare earth oxides alone or in a mixture with metal oxides and which is coated with a layer of silica functionalized with a coupling agent comprising at least one chemical function soluble in a hydrophobic solvent, and to a composition comprising at least one such particle. The present invention likewise relates to the method for preparing same and to various uses thereof.Type: ApplicationFiled: January 21, 2009Publication date: May 5, 2011Inventors: Olivier Raccurt, Samuel Jorice
-
Patent number: 7932091Abstract: Water-based colorant traced formulations (products) containing one or more water treatment agents, such as phosphonates, polyacrylic acids and/or polymers, co-polymers, terpolymers thereof, azoles, molybdate, polysilicates, phosphates, zinc, polyphosphates, etc., are provided wherein the water-soluble colorant is detectable in the visible light range of about 580-640 nm and is chemically inert relative to the water treatment agent(s). Measurement of an optical property of the colorant in the treated coolant water permits the concentration of the product therein to be ascertained, and the level of the product containing can be adjusted for controlling scale, corrosion, deposition, and/or microbial activity in commercial and/or industrial cooling water systems. These products may be reliably monitored and dosed to maintain a product level in treated water of 5 to 500 mg/L.Type: GrantFiled: January 31, 2007Date of Patent: April 26, 2011Assignee: ProChemTech International, Inc.Inventor: Timothy Keister
-
Publication number: 20110091979Abstract: Water collected in the area of coal beds has strongly positive ?13CDIC (12‰ to 22‰) that is readily distinguished from the negative ?13C of most surface and ground water (?8‰ to ?11‰). Furthermore, the DIC concentrations in coproduced water samples are also high (more than 100 mg C/L) compared to the 20 to 50 mg C/L in ambient surface and ground water of the region. The distinctively high ?13C and DIC concentrations allow the identification of surface and ground water that have incorporated CBNG-coproduced water.Type: ApplicationFiled: March 10, 2009Publication date: April 21, 2011Applicant: UNIVERSITY OF WYOMINGInventors: Shikha Sharma, Carol Frost
-
Publication number: 20110081723Abstract: A method of simultaneously detecting peroxide and nitrogen-based explosives includes the steps of applying a conversion reagent to a sample, the conversion reagent oxidizing in the presence of peroxide and inorganic nitrate explosives; applying a test reagent including a luminescent compound to the sample; exciting the luminescent compound with ultraviolet light; and simultaneously determining the presence of one or more explosives based on quenching, brightening or a shift in wavelength of the luminescence over time. Explosives may also be detected based on color changes of the sample. Optionally, phase transfer reagents, catalysts, colorimetric agents and zinc dust may be added to improve detection of explosives. Alternatively, an assay-type method may be utilized wherein a sample is added to the conversion and/or test reagents and the reagent is spotted on a substrate before exposure to ultraviolet light.Type: ApplicationFiled: June 2, 2009Publication date: April 7, 2011Applicant: REDXDEFENSE, LLCInventors: Dale R Miller, Sarah J Toal, Russell P Watson, William C Trogler
-
Patent number: 7919325Abstract: The present invention relates to an apparatus and methods for the identification or authentication of liquid products by the addition of an anti-Stokes marker. The invention features an apparatus and method for the identification of a liquid, dynamic or static, that includes adding an anti-Stokes luminescent marker compound to the liquid followed by exposing the compound to a light source of a known wavelength or known wavelengths and then detecting one or more shorter wavelength emissions from the marker, where the identity of the liquid is confirmed by the emission wavelength or wavelengths that are detected and quantified. The irradiating source of light includes, but is not limited to, a laser and other conventional light sources.Type: GrantFiled: May 24, 2004Date of Patent: April 5, 2011Assignee: Authentix, Inc.Inventors: Ian M. Eastwood, Erwin Dorland, Mohammed Salem Al-Jafari, David M. Goodall, Edmund T. Bergstrom
-
Patent number: 7919326Abstract: A method of tracking a status of a catalytic process in a mixture incorporates the use of Radio Frequency Identification (RFID) tags that have corrosive-sensitive coatings. The coatings are removable, by a corrosive in the mixture, at a rate that tracks with the rate at which a catalytic-driven process progresses. As coatings on the RFID tags are removed by the corrosive in the mixture, the digital signatures returned by the RFID tags change, in response to the corrosive damaging the RFID tags. By quantifying the number of damaged RFID tags, a determination can be made as to the progress status of the catalytic process.Type: GrantFiled: March 14, 2008Date of Patent: April 5, 2011Assignee: International Business Machines CorporationInventors: Robert L. Angell, James R. Kraemer
-
Patent number: 7908937Abstract: A method and an apparatus for detecting, locating, and quantifying contamination in a fluid flow system like a pipe or duct. This characterization technique uses a conservative and one or more interactive tracers that are injected into the fluid flow system and then monitored at another location in the system. Detection, location, and quantification are accomplished by analysis of the characteristic features of measured curves of tracer concentration.Type: GrantFiled: June 24, 2008Date of Patent: March 22, 2011Assignee: Vista Engineering Technologies LLCInventors: Wesley L. Bratton, Joseph W. Maresca, Jr.
-
Patent number: 7910371Abstract: A method of monitoring residual treating agent in treated water wherein fluorescent tracers are used to determine the concentration of treating agent in the water at two different treating agent dosages and the difference in the measured concentrations of the fluorescent tracer at the respective doses are correlated with the residual concentration of the treating agent. The fluorescence response at the different treating agent dosages is used to determine whether the system is overdosed or underdosed on a continuous basis and to control treating agent dose accordingly.Type: GrantFiled: January 20, 2005Date of Patent: March 22, 2011Assignee: Nalco CompanyInventor: Brian S. Johnson
-
Patent number: 7897408Abstract: First, an ammonium acetate solution and an acetate solution of a metal such as Cd or Zn are mixed, so as to form an ammonium complex of the metal. Next, an apoferritin solution, listeria apoferritin (listeria Dps) or their recombinant and thioacetic acid are added to the thus obtained reaction solution, which is maintained at a pH of from 4.0 to 9.0. By allowing the reaction solution to stand for 12 hours or more, a complex of a nanoparticle including CdS or ZnS and apoferritin or listeria Dps is produced.Type: GrantFiled: September 6, 2006Date of Patent: March 1, 2011Assignee: Japan Science and Technology AgencyInventor: Kenji Iwahori
-
Patent number: 7888053Abstract: Disclosed are methods for detecting antibody in a sample, where the antibody targets an antigen expressed by red blood cells or red blood cell ghosts. Rather than detecting the binding events between a particular antigen antibody pair (as in traditional agglutination based assays) the methods herein allow for multiplexed detection of clinically important allo-immune antibodies to blood group antigens. Specifically the method involves generating fluorescently encoded red blood cells or red blood cell ghosts with known antigen presentation and using them to detect the presence of antibody in serum/plasma with a fluorescent sandwich type immunoassay. The assay results can be read using flow cytometric or fluorescent microscope based imaging techniques.Type: GrantFiled: August 31, 2009Date of Patent: February 15, 2011Assignee: BioArray Solutions, LLCInventor: Sukanta Banerjee
-
Patent number: 7883902Abstract: The inventive method for dispersing a dry powder sample in a dispersion chamber consists in vacuuming the chamber with respect to the environment, in dispersing a dry powder in the chamber, by means of a suction generated by the rupture of a membrane which is torn.Type: GrantFiled: June 7, 2005Date of Patent: February 8, 2011Assignees: Occhio, Logistique Spatiale Wallonne-Wallonia Space LogisticsInventors: Vincent Chapeau, Christian Godino
-
Patent number: 7875457Abstract: To address counterfeit problems, for example, we propose a secure, flexible, and cost-effective authentication solution that can be integrated into conventional distribution logistic systems. The proposed solution for product authentication and distribution channel validation comprises three major components: 1) machine-readable Raman-active chemical taggant; 2) a taggant reader; and 3) a taggant eraser. The proposed solution is to control and validate the distribution channel by authenticating the origin of products. Authentication is accomplished by verification of distinct taggants associated with the articles, such as on its label, along with other product distribution information in optical, spatial-encoding indicia, such as a barcode. The taggant information is used to identify, validate, and distinguish the origin of the source of the articles, such as goods or products.Type: GrantFiled: May 12, 2005Date of Patent: January 25, 2011Assignee: Axsun Technologies, Inc.Inventors: Xiaomei Wang, Dale C. Flanders, Petros Kotidis, Christopher C. Cook
-
Patent number: 7875713Abstract: Derivatized cucurbiturils and cucurbituril assemblies formed thereby are disclosed. Also disclosed are binding pairs of the disclosed cucurbituril assemblies and polyamine structures, which are highly advantageous over the presently known affinity pairs and therefore can be efficiently utilized in a myriad of applications.Type: GrantFiled: September 5, 2004Date of Patent: January 25, 2011Assignee: Technion Research & Development Foundation Ltd.Inventor: Ehud Keinan
-
Patent number: 7867774Abstract: Various methods for altering surface characteristics of a microsphere are provided. One method includes coupling an enolic acid to the microsphere to modify the surface characteristics of the microsphere. The surface characteristics may include charge density and/or pKa. A reagent can be coupled to the microsphere via the enolic acid. The reagent may include a biomolecule. The modified surface characteristics may increase a stability of the reagent when the reagent is coupled to the microsphere. The modified surface characteristics may also improve performance of an assay carried out with the microsphere. Another embodiment relates to a microsphere that includes an enolic acid coupled to a polymer core of the microsphere such that the enolic acid modifies surface characteristics of the microsphere. A reagent can be coupled to the microsphere via the enolic acid.Type: GrantFiled: October 11, 2005Date of Patent: January 11, 2011Assignee: Luminex CorporationInventors: Ananda G. Lugade, Kurt D. Hoffacker
-
Publication number: 20100330680Abstract: The present invention provides methods for enhancing the fragmentation of peptides for mass spectrometry by modifying the peptides with a tagging reagent containing a functional group, such as a tertiary amine, having a greater gas-phase basicity than the amide backbone of the peptide. These high gas-phase basicity functional groups are attached to a peptide by reacting the tagging reagent to one or more available carboxylic acid groups of the peptide. Linking these high gas-phase functional groups to the peptides leads to higher charge state ions from electrospray ionization mass spectrometry (ESI-MS), which fragment more extensively during fragmentation techniques, particularly non-ergodic fragmentation techniques such as electron capture dissociation (ECD) and electron transfer dissociation (ETD).Type: ApplicationFiled: April 14, 2010Publication date: December 30, 2010Inventors: Brian L. Frey, April L. Jue, Casey J. Krusemark, Lloyd M. Smith, Joshua J. Coon
-
Patent number: 7858399Abstract: The present invention relates to immobilized procainamide analogs, as well as to a method of making immobilized procainamide analogs. These immobilized analogs are prepared by activating the carboxyl group on a substituted p-benzoic acid derivative toward nucleophilic attack; reacting the activated benzoic acid derivative with a polyamine to produce the benzoic acid derivative of Formula 3: and binding the benzoic acid derivative of Formula 3 to a latex polymer having functional groups that react with aliphatic amino groups. A method of conducting an immunoassay using the immobilized procainamide analog Formula 3 is described, comprising the steps of preparing a solution comprising said immobilized procainamide analog; adding a sample suspected of containing procainamide to said solution; adding an anti-procainamide antibody to said solution and observing the rate of increase in solution turbidity following antibody addition.Type: GrantFiled: August 28, 2007Date of Patent: December 28, 2010Assignee: Siemens Healthcare Diagnostics Inc.Inventors: Victor P. Chu, Zhu Teng, Steve P. A. Goss, Ronald A. Edwards, Kelle M. Garvey, Timothy J. Gorzynski, William D. Bedzyk
-
Patent number: 7858373Abstract: A method for marking a petroleum hydrocarbon, a biodiesel fuel or an ethanol fuel, by adding an organic marker compound.Type: GrantFiled: January 22, 2007Date of Patent: December 28, 2010Assignee: Rohm and Haas CompanyInventors: Rajiv Manohar Banavali, Randall Wayne Stephens
-
Publication number: 20100317116Abstract: The present invention is generally directed to compositions, methods, and systems for performing single-molecule, real-time analysis of analytical reactions in which protein synthesis is occurring. The ability to analyze such reactions provides an opportunity to study those reactions as well as to potentially identify factors and/or approaches for impacting such reactions, e.g., to either enhance, inhibit, or otherwise affect such reactions including, but not limited to, affecting the reaction rate, processivity, fidelity, duration, and the like.Type: ApplicationFiled: June 11, 2010Publication date: December 16, 2010Applicant: Pacific Biosciences of California, Inc.Inventors: Benjamin Flusberg, Stephen Turner, Jonas Korlach, Eric Schadt
-
Patent number: 7846392Abstract: The present invention provides novel microfluidic devices and methods for preventing/ameliorating formation of precipitate blockages in microfluidic devices. In particular, the devices and methods of the invention utilize microchannels of specific cross-sectional configuration and of specific arrangement as well as application of AC current orthogonal to the direction of fluid flow, in order to prevent/ameliorate formation of precipitate blockages in microfluidic devices.Type: GrantFiled: June 18, 2007Date of Patent: December 7, 2010Assignee: Caliper Life Sciences, Inc.Inventor: Andrea W. Chow
-
Publication number: 20100304491Abstract: Described herein are methods directed to the use of the nanodot taggants in detection and/or simulation scenarios. The nanodot taggants are based on quantum dots and may be engineered so as to have particular emission and or absorbance spectral characteristics. The nanodots are extremely small, i.e., on the order of nanometers in size, and thus do not, in some cases, behave as particles, but rather are able to be carried along and through structures like a gas.Type: ApplicationFiled: August 13, 2010Publication date: December 2, 2010Inventor: Scott Earl McNeil
-
Patent number: 7842505Abstract: A fluorescent labeling reagent of the present invention includes an inorganic fluorescent particle and a material (A) having a material (B) of biological origin adsorbed or bound thereto. The inorganic fluorescent particle is integrated with the material (A) so as to form the reagent of the present invention. The inorganic fluorescent particle used in the present invention is capable of emitting light with a wavelength of 650 nm to 1600 nm in the infrared region or the near-infrared region which can be detected by means of Si—CCD or InGaAs—PD and can penetrate an H2O rich sample when excited by light with a wavelength of 650 nm or longer which has the shortest transparent wavelength of AlInGaP-LD including oxygen adsorption type hemoglobin used for DVDs etc.Type: GrantFiled: February 26, 2007Date of Patent: November 30, 2010Assignee: Keio UniversityInventors: Kunihiro Noda, Ryo Asakura, Daisuke Saito, Tetsuhiko Isobe, Tomohiro Takagi, Hideki Aizawa, Michio Ohkubo
-
Publication number: 20100297774Abstract: A method of identifying a product comprises forming a tagged product by adding to said product a tracer material comprising at least one tracer compound which is acceptable for use as an additive in food and subsequently analysing a sample of said product to determine the presence of said tracer compound thereby to determine whether said sample is a sample of the tagged product. The method is especially useful for the identification of vegetable oil products from sustainably managed sources. The use of permitted food additives as tracers enables the product to be identified in the supply chain whilst also allowing it to be used safely in foodstuffs if required.Type: ApplicationFiled: August 4, 2008Publication date: November 25, 2010Applicant: JOHNSON MATTHEY PLCInventors: Darrell Green, Duncan William John McCallien, Christopher Thomas Llewellyn
-
Patent number: 7820446Abstract: A transparent marker casing for use with a tracking system, comprising a material that is transparent to radiation emanating from at least one marker, wherein the marker casing is formed such that it at least partially surrounds the at least one marker. The casing can include a moisture sensor that can detect moisture or liquid on a surface of the casing and provide a signal indicative of the presence of moisture.Type: GrantFiled: November 18, 2005Date of Patent: October 26, 2010Assignee: BrainLAB AGInventors: Thomas Feilkas, Hansjörg Huber
-
Patent number: 7820962Abstract: An ion mobility spectrometer has a drift chamber (1) with an inlet (2) at one end by which a gas or vapor being analyzed is supplied to the chamber. After ionization, molecules are admitted through a gate 8 and flow along a drift region (9) to a collector plate (11). A drift gas is flowed through the drift region against the flow of ionized molecules and is circulated along a flow path (31, 32, 40) and (30), which includes a chamber (50) including a dopant. The dopant is 2,4-pentanedione, which has been found to enhance the detection of a number of compounds especially toxic industrial chemicals and nitrogen compounds, such as those present in the breath of mammals.Type: GrantFiled: May 12, 2006Date of Patent: October 26, 2010Assignee: Smiths Detection - Watford LimitedInventors: Paul Grant Wynn, Henry Paul McIntyre
-
Patent number: 7820108Abstract: The present invention includes a method and apparatus for monitoring drug compliance by detecting markers, such as odors, upon exhalation by a patient after medication is taken, wherein such markers result either directly from the medication itself or from an additive combined with the medication. In the case of olfactory markers, the invention preferably utilizes electronic sensor technology, such as the commercial devices referred to as “artificial noses” or “electronic noses,” to non-invasively monitor compliance. The invention further includes a reporting system capable of tracking compliance (remote or proximate) and providing the necessary alerts.Type: GrantFiled: November 26, 2003Date of Patent: October 26, 2010Assignee: University of Florida Research Foundation, Inc.Inventors: Samsun Lampotang, Richard J. Melker, David N. Silverman
-
Patent number: 7820963Abstract: A method for identifying a biological analyte that is affected by a stressor is disclosed in which two substantially identical biological samples are provided, with a first sample being a control sample and a second sample being an experimental sample. The control sample is grown with a nutrient having an isotope of a first atom, whereas the experimental sample is grown with a nutrient having a second isotope of the first atom. The experimental sample is grown with a stressing agent and regimen. The samples are admixed, and the formed composite is mass spectroscopically assayed for analyte peaks. The ratio of first isotope to second isotope is determined for the peaks, as is a sample median isotopic ratio. The ratio for assayed analyte peaks is compared with the median ratio. An analyte whose isotopic ratio significantly deviates from the median ratio is an analyte affected by the stressing agent.Type: GrantFiled: August 5, 2008Date of Patent: October 26, 2010Assignee: Metabolic Alayses, Inc.Inventor: Christopher William Ward Beecher
-
Patent number: 7811517Abstract: A method of using an inert fluorescent tracer in a system that contains liquids in contact with solid surfaces and wherein said system contains a corrosive environment, is described and claimed, as is a method of using an inert fluorescent tracer to trace the corrosive material itself. Combinations of inert fluorescent tracers in corrosive materials are also described and claimed.Type: GrantFiled: March 4, 2008Date of Patent: October 12, 2010Assignee: Nalco CompanyInventors: John E. Hoots, Barbara H. Davis
-
Patent number: 7807468Abstract: Methods of marking pharmaceutical products for use in clinical trials and for determining the origin or authenticity of the marked products are provided that use a variety of natural materials as markers. The natural materials have unique genetically controlled micromorphological structures that can be identified using enhanced visualization techniques. For example, cellulosic plant materials, sporopollenin and diatoms can be used as the natural materials. The natural materials are added to pharmaceutical products at sufficiently low levels so as not to have any significant effect on the products other than serving as markers. Dyes and reactants can be added to the natural materials to provide secondary markers. The markers can be identified in stool samples collected during clinical trials to prove that a particular pharmaceutical product has been ingested by a test subject.Type: GrantFiled: September 21, 2005Date of Patent: October 5, 2010Inventor: Lynn S. Bates